NEW YORK (GenomeWeb News) – Nastech Pharmaceutical has obtained a Phase I Small Business Innovation Research grant from the National Institutes of Health to help it develop small-interfering RNA influenza drugs.
The company did not disclose the mount of the grant but Phase I SBIRs typically do not exceed $100,000.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.